The Impact Accelerator, managed by CDC, was created in 2015 to develop the market for impact investing in some of the most remote and challenging business environments in the world. After two years of investing, the team has produced a publication, which makes a series of practical recommendations to investors in emerging markets on how to build an impact-focused portfolio.
The report also highlights the investments its made since 2015. These include:
- 14 Trees: A joint venture with LafargeHolcim, a building materials manufacturer, to increase the production of a low-carbon alternative to bricks in Africa.
- Virunga Energy: A hydo-electric power company providing electricity to eastern Democratic Republic of the Congo, a region which has endured two decades of conflict has just three per cent electrification
- Africa Improved Foods: A co-investment with Dutch company Royal DSM, which produces fortified foods to address malnutrition in children in Rwanda and Ethiopia.
You can read the report in full here.
CDC is the UK government-owned development finance institution. CDC’s mission is to support the building of businesses throughout Africa and South Asia, to create jobs and making a lasting difference to people’s lives in some of the world’s poorest places.
We provide investment capital in all its forms, including equity, debt, mezzanine and guarantees, and this capital is typically used to fund growth. This capital is provided directly and through fund managers that are aligned with our aims.
CDC uses its own balance sheet to invest and has net assets of £3.4bn.